Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT

BACKGROUND: There is no information on the impact of donor type in allogeneic hematopoietic stem cell transplantation (HCT) using homogeneous graft-versus-host (GVHD) prophylaxis with post-transplant cyclophosphamide (PTCy) in acute lymphoblastic leukemia (ALL). METHODS: We retrospectively analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanz, Jaime, Galimard, Jacques-Emmanuel, Labopin, Myriam, Afanasyev, Boris, Sergeevich, Moiseev Ivan, Angelucci, Emanuele, Kröger, Nicolaus, Koc, Yener, Ciceri, Fabio, Diez-Martin, J. L., Arat, Mutlu, Sica, Simona, Rovira, Montserrat, Aljurf, Mahmoud, Tischer, Johanna, Savani, Bipin, Ruggeri, Annalisa, Nagler, Arnon, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161915/
https://www.ncbi.nlm.nih.gov/pubmed/34049582
http://dx.doi.org/10.1186/s13045-021-01094-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161915/
https://www.ncbi.nlm.nih.gov/pubmed/34049582
http://dx.doi.org/10.1186/s13045-021-01094-2

Ejemplares similares